Benefits of Substantive Examination for Pharmaceutical Patent Claims

More documents

Recommendations

Info

AIDS drug access blocked by ‘New Use’ patent on zidovudine
New use patent claims in South Africa Cancer drug Imatinib Mesylate Patents: Evergreening Trend 1993 + 20 (2013) 1997 + 20 (2017) 2002 + 20 (2022) Imanitib compound and all its salts patented. (This patent expires in SA this year) New Use of Imatinib Mesylate salt of Patented imatinib patented Granted in S. Africa
Page 1 and 2: South Africa’s IP Policy Way Forw
Page 3 and 4: Local Patents linked to Local Price
Page 5 and 6: Vital Importance of Generic Competi
Page 8 and 9: SOUTH AFRICA - TRIPS FLEXIBILITIES?
Page 12 and 13: A number of countries have already
Page 14 and 15: Patent Filing Trends in India • M
Page 18 and 19: Developing countries & TRIPS ‣ Re
Page 21 and 22: India High prices of patented drugs
Page 23 and 24: 200 150 Indian Patent Office 130.24
Page 25 and 26: “ p]olicy makers in the health ar
Page 27 and 28: First CL in India Cancer Drug-Soraf

Benefits of Substantive Examination for Pharmaceutical Patent Claims

Create successful ePaper yourself

Delete template?

Save as template?